Assessing the Role of the Autonomic Nervous System as a Driver of Sleep Quality in Patients With Multiple Sclerosis: Observation Study
JMIR Neurotechnology · 2024
DOI: 10.2196/48148 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIR Neurotechnology, 2024. Verfasst von Max Moebus und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science Eidgenössische Technische Hochschule Zürich (ETH Zurich) Zurich Switzerland. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaf
Abstract (Originalsprache)
Background
Low sleep quality is a common symptom of multiple sclerosis (MS) and substantially decreases patients’ quality of life. The autonomic nervous system (ANS) is crucial to healthy sleep, and the transition from wake to sleep produces the largest shift in autonomic activity we experience every day. For patients with MS, the ANS is often impaired. The relationship between the ANS and perceived sleep quality in patients with MS remains elusive.
Objective
In this study, we aim to quantify the impact of the ANS and MS on perceived sleep quality.
Methods
We monitored 77 participants over 2 weeks using an arm-worn wearable sensor and a custom smartphone app. Besides recording daily perceived sleep quality, we continuously recorded participants’ heart rate (HR) and HR variability on a per-second basis, as well as stress, activity, and the weather (20,700 hours of sensor data).
Results
During sleep, we found that reduced HR variability and increased motion led to lower perceived sleep quality in patients with MS (n=53) as well as the age- and gender-matched control group (n=24). An activated stress response (high sympathetic activity and low parasympathetic activity) while asleep resulted in lower perceived sleep quality. For patients with MS, an activated stress response while asleep reduced perceived sleep quality more heavily than in the control group. Similarly, the effect of increased stress levels throughout the day is particularly severe for patients with MS. For patients with MS, we found that stress correlated negatively with minimal observed HR while asleep and might even affect their daily routine. We found that patients with MS with more severe impairments generally recorded lower perceived sleep quality than patients with MS with less severe disease progression.
Conclusions
For patients with MS, stress throughout the day and an activated stress response while asleep play a crucial role in determining sleep quality, whereas this is less important for healthy individuals. Besides ensuring an adequate sleep duration, patients with MS might thus work to reduce stressors, which seem to have a particularly negative effect on sleep quality. Generally, however, sleep quality decreases with MS disease progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer Science Eidgenössische Technische Hochschule Zürich (ETH Zurich) Zurich Switzerland.
- Neuroimmunology Department University Hospital Zürich Zurich Switzerland.
ORCID-Profile: Max Moebus, Marc Hilty, Pietro Oldrati, Liliana Barrios, Christian Holz
Zitieren
APA
Moebus, M., Hilty, M., Oldrati, P., Barrios, L., PHRT Author Consortium, & Holz, C. (2024). Assessing the Role of the Autonomic Nervous System as a Driver of Sleep Quality in Patients With Multiple Sclerosis: Observation Study. JMIR Neurotechnology. https://doi.org/10.2196/48148
Vancouver
Moebus M, Hilty M, Oldrati P, Barrios L, PHRT Author Consortium, Holz C. Assessing the Role of the Autonomic Nervous System as a Driver of Sleep Quality in Patients With Multiple Sclerosis: Observation Study. JMIR Neurotechnology. 2024. doi:10.2196/48148
BibTeX
@article{Moebus2024,
author = {Moebus, Max and Hilty, Marc and Oldrati, Pietro and Barrios, Liliana and PHRT Author Consortium, PHRT Author Consortium and Holz, Christian},
title = {Assessing the Role of the Autonomic Nervous System as a Driver of Sleep Quality in Patients With Multiple Sclerosis: Observation Study},
journal = {JMIR Neurotechnology},
year = {2024},
doi = {10.2196/48148}
}
EUVIMED